Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 342 participants.
Also called NCT01291641
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 342 participants
- Registry
-
NCT01291641
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01291641. Randomized; single masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2016-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease
- Acronym
- IMPACTonIMT
- Condition
- Hyperlipidemias
- Intervention (Drug)
- HMG-CoA Reductase Inhibitor
- Intervention (Drug)
- Probucol
- Intervention (Drug)
- Cilostazol
- Lead sponsor
- Seoul National University Hospital
- Collaborator
- Korea Otsuka Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct01291641- Content hash
9052730b8927cfda4d57b80f1eb454643d2ed61f3e7046a34b2987d08055a55e